Prevention of Acute Rejection by Basiliximab (Simulect^<【○!R】>) and Its Safety in de novo Renal Transplant Patients

• TANABE Kazunari

  Department of Urology, Tokyo Women's Medical University

• TOMA Hiroshi

  Department of Urology, Tokyo Women's Medical University

• TAKAHASHI Kota

  Department of Urology, Niigata University School of Medicine

• FUKAO Katashi

  Department of Surgery, Institute of Clinical medicine, University of Tsukuba

• AGISHI Tetsuzo

  Department of Surgery III, Tokyo Women's Medical University

• FUCHINOUE Shohei

  Department of Surgery III, Tokyo Women's Medical University

• OHARA Takehiro

  Department of Nephrology, Toho University School of Medicine

• UCHIDA Kazuharu

  Nagoya Daini Red Cross Hospital

• KINUKAWA Tsuneo

  Shakaihoken Chukyo Hospital

• YOSHIMURA Norio

  Department of Organ Transplant and Endocrine Surgery, Kyoto Prefectural University of Medicine

• TAKAHARA Shiro

  Department of Urology, Osaka University Medical School

• OSHIMA Shinnichi

  Department of Urology, Nagoya University School of Medicine

Bibliographic Information

Other Title

• わが国における新規腎移植患者に対するBasiliximab(シムレクト)の急性拒絶反塔抑制効果および安全性の検討

Journal

• 移植

  移植 37 (1), 18-31, 2002-02-10

Keywords

• Simulect^<【○!R】>) (Basiliximab)
• Chimeric monoclonal antibody
• Renal transplantation
• IL-2(interleukin-2)
• CD25

Details

• CRID: 1571135649567712640
• NII Article ID: 10007908867
• NII Book ID: AN00014749
• ISSN: 05787947
• Web Site: https://search.jamas.or.jp/link/ui/2002154601
• Text Lang: ja
• Data Source:
  • CiNii Articles